Digital outpatient care platform Meddo has announced the acquisition of digital prescription platform Doxper in a cash and stock deal.
Doxper is a digital pen and encoded paper-based clinical documentation system that is powered by cloud computing, AI and machine learning. Everything written on the encoded paper is recorded and transferred to the cloud, allowing for seamless healthcare data gathering.
The startup was founded in 2015 by Randeep Singh, Shailesh Prithani and Pawan Jain and is based in Mumbai. Its solution helps healthcare organisations in health record management, patient engagement, and streamlines the treatment plan with automated reminders.
Founded in 2018 by Saurabh Kochhar, Meddo transforms physical clinics into digital healthcare centres with advanced ambulatory care systems. It claims to have over 250 digitised smart clinics in Delhi and Bengaluru. Meddo was named in Inc42’s healthcare Startup Watchlist for 2021.
Talking about the rationale behind the acquisition, Kochhar said, “Enabling Meddo’s one-stop care for millions of patients across the Doxper network, in addition to their prescription technology, creates the right ecosystem to fundamentally transform outpatient care.”
With Doxper in its fold, Meddo plans to scale-up to 1000-plus clinics within the next 12-15 months across 10 cities in India. In recent months, Meddo has launched solutions such as L1 COVID centres, teleconsultation services, diagnostic solutions and a healthcare membership called MeddoSure.
Apart from Doxper, companies like Farmako, Tattvan E-Clinics, WonDrx, Portea Medicals, Lybrate, DocsApp, MedCords among others are also working towards solving the same issue i.e, the problem of healthcare data deficiency.
According to data from Inc42 Plus, India’s healthtech market is expected to reach a market value of $21 Bn by 2025. Between 2014 and March 2020, over $2.3 Bn was infused in Indian healthtech startups. As of now, there are more than 290 funded healthtech startups in India.